Recent therapeutic advances in urothelial carcinoma : A paradigm shift in disease management - Bellmunt, J. (Department of Medical Oncology. Beth Israel Deaconess Medical Center and IMIM-PSMAR Lab. Harvard Medical School) ; Valderrama, B.P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Puente, J. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Grande, Enrique (MD Anderson Cancer Center Madrid) ; Bolós, M.V. (Pfizer) ; Laínez, Nuria (Hospital Universitario de Navarra) ; Vázquez, S. (Hospital Universitario Lucus Augusti (Lugo)) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Climent, Miguel Ángel (Department of Medical Oncology. Valencia Institute of Oncology Foundation) ; Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ; Arranz Alija, Jose Ángel (Hospital General Universitario Gregorio Marañón) ; Durán, Ignacio (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.